Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2018, Article ID 1346104, 7 pages
https://doi.org/10.1155/2018/1346104
Research Article

Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study

1Department of Medicine, Weill Bugando School of Medicine, 1464 Mwanza, Tanzania
2Department of Medicine, College of Health Sciences, University of Dodoma, 395 Dodoma, Tanzania
3Department of Infectious Disease, Kilimanjaro Christian Medical College, Moshi, Tanzania
4Department of Medicine, Bugando Medical Centre, 1370 Mwanza, Tanzania

Correspondence should be addressed to Daniel W. Gunda; moc.oohay@2002ver_leinad

Received 23 April 2018; Accepted 19 June 2018; Published 4 July 2018

Academic Editor: José A. Oteo

Copyright © 2018 Daniel W. Gunda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, HIV Fact Sheet 2016, Global Statistics, UNAIDS, Geneva, Switzerland, 2016.
  2. WHO, Global Health Observatory (GHO) Data, WHO/HIV-AIDS, Geneva, Switzerland, 2015.
  3. MOHSW, Global AIDS Response Country Progress Report, MOHSW, Dar es salaam, Tanzania, 2014.
  4. N. Martin and Q. Sattentau, “Cell-to-cell HIV-1 spread and its implications for immune evasion,” Current Opinion in HIV and AIDS, vol. 4, no. 2, pp. 143–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Alexaki, Y. Liu, and B. Wigdahl, “Cellular reservoirs of HIV-1 and their role in viral persistence,” Current HIV Research, vol. 6, no. 5, pp. 388–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. S. Ford, C. E. Puronen, and I. Sereti, “Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm,” Current Opinion in HIV and AIDS, vol. 4, no. 3, pp. 206–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Brooks, J. E. Kaplan, K. K. Holmes, C. Benson, A. Pau, and H. Masur, “HIV-associated opportunistic infections–going, going, but not gone: the continued need for prevention and treatment guidelines,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 609–611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. WHO, Global Tuberculosis Report 2016, World Health Organization, Geneva, Switzerland, 2016.
  9. WHO, Interim Policy on Collaborative TB/HIV Activities, WHO, Geneva, Switzerland, 2004.
  10. WHO, Global tuberculosis control 2011, WHO, Geneva, Switzerland, 2011.
  11. F. J. Palella Jr., K. M. Delaney, A. C. Moorman et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection,” New England Journal of Medicine, vol. 338, no. 13, pp. 853–860, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. K. Gandhi, “What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?” Medical Journal of Australia, vol. 190, no. 8, p. 461, 2009. View at Google Scholar
  13. G. Reniers, E. Slaymaker, J. Nakiyingi-Miiro et al., “Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA),” AIDS, vol. 28, no. 4, pp. S533–S542, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Egger, M. May, G. Chêne et al., “Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies,” The Lancet, vol. 360, no. 9327, pp. 119–129, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. D. Lawn, R. Wood, K. M. De Cock, K. Kranzer, J. J. Lewis, and G. J. Churchyard, “Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources,” The Lancet Infectious Diseases, vol. 10, no. 7, pp. 489–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Badri, D. Wilson, and R. Wood, “Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study,” The Lancet, vol. 359, no. 9323, pp. 2059–2064, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Martin-Echevarria, S. Serrano-Villar, T. Sainz et al., “Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy,” International Journal of Tuberculosis and Lung Disease, vol. 18, no. 9, pp. 1080–1084, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gupta, R. Wood, R. Kaplan, L.-G. Bekker, and S. D. Lawn, “Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa,” PLoS One, vol. 8, no. 2, Article ID e55824, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. MOHSW, Manual of the National Tuberculosis and Leprosy programme in Tanzania, Ministry of Health and Social Welfaire, Dar es Salaam, Tanzania, 5th edition, 2006.
  20. A. Van Rie, D. Westreich, and I. Sanne, “Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies,” Journal of Acquired Immune Deficiency Syndromes, vol. 56, no. 4, pp. 349–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Liu, A. Makubi, P. Drain et al., “Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy,” AIDS, vol. 29, no. 11, pp. 1391–1399, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Hermans, A. N. Kiragga, P. Schaefer, A. Kambugu, A. I. M. Hoepelman, and Y. C. Manabe, “Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa,” PLoS One, vol. 5, no. 5, Article ID e10527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Girardi, G. Antonucci, P. Vanacore et al., “Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection,” AIDS, vol. 14, no. 13, pp. 1985–1991, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. D. Lawn, M. Badri, and R. Wood, “Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort,” AIDS, vol. 19, no. 18, pp. 2109–2116, 2005. View at Publisher · View at Google Scholar
  25. S. D. Lawn, L. Myer, D. Edwards, L.-G. Bekker, and R. Wood, “Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa,” AIDS, vol. 23, no. 13, pp. 1717–1725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Habte, A. Yami, F. Alemseged et al., “Predictors of HIV serodiscordance among couples in Southwestern Ethiopia,” Journal of the International Association of Providers of AIDS Care, vol. 14, no. 3, pp. 234–240, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Moore, J. I. Kim, S. Sonawane et al., “Progress toward antibody-induced transplantation tolerance,” Critical Reviews™ in Immunology, vol. 27, no. 2, pp. 167–218, 2007. View at Publisher · View at Google Scholar
  28. A. Gupta, R. Wood, R. Kaplan, L.-G. Bekker, and S. D. Lawn, “Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community,” PLoS One, vol. 7, no. 3, Article ID e34156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Neyrolles and L. Quintana-Murci, “Sexual inequality in tuberculosis,” PLoS Medicine, vol. 6, no. 12, Article ID e1000199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. W. Uplekar, S. Rangan, M. G. Weiss, J. Ogden, M. W. Borgdorff, and P. Hudelson, “Attention to gender issues in tuberculosis control,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 220–224, 2001. View at Google Scholar
  31. A. J. Codlin, E. Qadeer, I. Ara et al., “Gender differences in tuberculosis notification in Pakistan,” American Journal of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 514–517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Onifade, A. M. Bayer, R. Montoya et al., “Gender-related factors influencing tuberculosis control in shantytowns: a qualitative study,” BMC Public Health, vol. 10, no. 1, p. 381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Rubaihayo, N. M. Tumwesigye, J. Konde-Lule et al., “Trends and predictors of mortality among HIV positive patients in the era of highly active antiretroviral therapy in Uganda,” Infectious Disease Reports, vol. 7, no. 3, p. 5967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Dembele, N. Saleri, A. C. Carvalho et al., “Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 3, pp. 318–323, 2010. View at Google Scholar
  35. I. Pathmanathan, E. K. Dokubo, R. W. Shiraishi et al., “Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012,” PLoS One, vol. 12, no. 3, Article ID e0173309, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Miranda, M. Morgan, L. Jamal et al., “Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001,” PLoS One, vol. 2, no. 9, Article ID e826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. D. Moore and J. C. Keruly, “CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression,” Clinical Infectious Diseases, vol. 44, no. 3, pp. 441–446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. P. W. Hunt, S. G. Deeks, B. Rodriguez et al., “Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy,” AIDS, vol. 17, no. 13, pp. 1907–1915, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. V. Baker, G. Peng, J. Rapkin et al., “Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases,” JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 5, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K. A. Lichtenstein, C. Armon, K. Buchacz et al., “Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study,” Clinical Infectious Diseases, vol. 51, no. 4, pp. 435–447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Melkamu, B. Seyoum, and Y. Dessie, “Determinants of tuberculosis infection among adult HIV positives attending clinical care in western Ethiopia: a case-control study,” AIDS Research and Treatment, vol. 2013, Article ID 279876, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. L. F. Assebe, H. L. Reda, A. D. Wubeneh, W. T. Lerebo, and S. M. Lambert, “The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study,” BMC Public Health, vol. 15, no. 1, p. 346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Akolo and S. Woldehanna, “Treatment of latent tuberculosis infection in HIV infected persons,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD000171, 2010. View at Publisher · View at Google Scholar
  44. S. D. Lawn, K. Kranzer, and R. Wood, “Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings,” Clinics in Chest Medicine, vol. 30, no. 4, pp. 685–699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. D. Yirdaw, D. Jerene, Z. Gashu et al., “Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia,” PLoS One, vol. 9, no. 8, Article ID e104557, 2014. View at Publisher · View at Google Scholar · View at Scopus